MetaCap

Illumina Inc. Company Profile

NASDAQ: ILMNHealth CareMedical SpecialitiesUSD

192.82-7.83 (-3.90%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Illumina at a glance

Illumina Inc. (NASDAQ: ILMN) is a Medical Specialities company in the Health Care sector headquartered in San Diego, CA. Illumina is led by Mr. Jacob Thaysen Ph.D. and employs about 8,600 people. The company's shares have traded publicly since 2000.

At a market capitalization of $29.15 billion, it is considered a large-cap company. ILMN is a member of the SP500. Its SEC Central Index Key (CIK) is 0001110803, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Illumina do?

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Business description based on the company's public filings.

Company information

Legal name
Illumina Inc.
Ticker
NASDAQ: ILMN
Industry
Medical Specialities
CEO
Mr. Jacob Thaysen Ph.D.
Employees
8,600
Headquarters
5200 Illumina Way, San Diego, CA, United States
Phone
858 202 4500
IPO year
2000
Market cap
$29.15B
SEC CIK
0001110803

Index membership

Companies similar to Illumina

ILMN peer companies
CompanyPrice% ChgMarket capCompare
LHLabcorp Holdings Inc.367.13-0.47%$29.81Bvs ILMN
DGXQuest Diagnostics Incorporated258.28-0.31%$28.42Bvs ILMN
CNCCentene Corporation63.78-2.74%$31.58Bvs ILMN
GHGuardant Health Inc.145.83+0.16%$19.73Bvs ILMN
NTRANatera Inc.273.40-5.70%$39.64Bvs ILMN
HUMHumana Inc.390.00+2.63%$46.84Bvs ILMN
MOHMolina Healthcare Inc198.39-2.43%$10.36Bvs ILMN
HSICHenry Schein Inc.83.52-1.51%$9.23Bvs ILMN

Related